Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors

Article


Esposito, M., Zhao, Lu, Fung, Tsz Kan, Rane, Jayant K, Wilson, Amanda, Martin, Nadine, Gil, Jesus, Leung, Anskar Y, Ashworth, Alan and Eric So, Chi Wai 2015. Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors. Nature Medicine. 21 (12), pp. 1481-1490.
AuthorsEsposito, M., Zhao, Lu, Fung, Tsz Kan, Rane, Jayant K, Wilson, Amanda, Martin, Nadine, Gil, Jesus, Leung, Anskar Y, Ashworth, Alan and Eric So, Chi Wai
Abstract

Acute myeloid leukemia (AML) is mostly driven by oncogenic transcription factors,
which have been classically viewed as intractable targets using small molecule inhibitor
approaches. Here, we demonstrate that AML driven by repressive transcription factors
including AML1-ETO and PML-RARα are extremely sensitive to Poly (ADP-ribose)
Polymerase (PARP) inhibitor (PARPi), in part due to their suppressed expression of key
homologous recombination genes and thus compromised DNA damage response (DDR).
In contrast, leukemia driven by MLL fusions with dominant transactivation ability is
proficient in DDR and insensitive to PARP inhibition. Intriguing, depletion of an MLL
downstream target, Hoxa9 that activates expression of various HR genes, impairs DDR
and sensitizes MLL leukemia to PARPi. Conversely, Hoxa9 over-expression confers
PARPi resistance to AML1-ETO and PML-RARα transformed cells. Together, these
studies describe a potential utility of PARPi-induced synthetic lethality for leukemia
treatment and reveal a novel molecular mechanism governing PARPi sensitivity in AML.

JournalNature Medicine
Journal citation21 (12), pp. 1481-1490
ISSN1546-170X
1078-8956
Year2015
PublisherNature Publishing Group
Accepted author manuscript
License
CC BY
Digital Object Identifier (DOI)doi:10.1038/nm.3993
Publication dates
Print23 Nov 2015
Publication process dates
Deposited05 Jul 2016
Accepted14 Oct 2015
Copyright information© 2015 The author
Permalink -

https://repository.uel.ac.uk/item/853x5

  • 3
    total views
  • 44
    total downloads
  • 1
    views this month
  • 5
    downloads this month

Related outputs

Exploiting DNA damage repair defects for effective targeting of acute myeloid leukaemia by PARP inhibitors
Esposito, M., Zhao, L., Fung, T.K., Rane, J., Wilson, A., Martin, N., Gil, J., Leung, A.Y., Ashworth, A. and So, C.W.E. 2016. Exploiting DNA damage repair defects for effective targeting of acute myeloid leukaemia by PARP inhibitors. European Journal of Cancer. 61 (Supp.1), p. S24.
Hematopoietic stem cells meet induced pluripotent stem cells technology
Esposito, M. 2016. Hematopoietic stem cells meet induced pluripotent stem cells technology. Haematologica. 101 (9), pp. 999-1001.
Angiotensin receptor I stimulates osteoprogenitor proliferation through TGFβ-mediated signaling
Querques, Francesca, Cantilena, Bruno, Cozzolino, Carmine, Esposito, M., Passaro, Fabiana, Parisi, Silvia, Lombardo, Barbara, Russo, Tommaso and Pastore, Lucio 2015. Angiotensin receptor I stimulates osteoprogenitor proliferation through TGFβ-mediated signaling. Journal of Cellular Physiology. 230 (7), pp. 1466-1474.